Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
5
Mins
30 May 2023
Interview: Janis Abkowitz
Janis Abkowitz | Head, Division of Hematology, University of Washington, Seattle, USA; Adjunct Professor of Genome Sciences, University of…
6
Mins
19 May 2023
Interview: Cynthia Dunbar
Cynthia Dunbar – Secretary, American Society of Hematology (ASH); Chief, Translational Stem Cell Biology Branch, and Head, Molecular…
12 May 2023
Adults with Acute Myeloid Leukaemia and Myelodysplastic Syndrome Commonly Experience Nutrition-Related Challenges
Adults with acute myeloid leukaemia and myelodysplastic syndrome commonly experience nutrition-related challenges…
9 May 2023
Gene Therapy in Haemophilia: ASH Congress Highlights
This podcast explores the current burden of haemophilia; namely the geographical prevalence and treatment regimes.
20 Mar 2023
Updates on CAR-NK Cells
This presentation offers insight into chimeric antigen receptor-transduced (CAR) natural killer (NK) cells, providing an update on the involvement of these cells in a host of topics, from stem cell transplantation to cancer.
27 Feb 2023
Update on AL Amyloidosis
This webinar discusses the critical factors involved in amyloidosis diagnosis, prognosis and management, describing both haematologic and organ responses to treatment. The presentation also delves into the origins of cardiac amyloidosis, outlining investigations required to assess organ involvement and establish a diagnosis.
11
Mins
15 Feb 2023
Realising the Promise of Gene Therapy for Haemophilia: Current Status and Future Innovations
Gene therapy for haemophilia A and B was discussed during several sessions at the 64th American Society of Hematology (ASH) Annual Meeting, held 10th–13th December 2022.
8 Dec 2022
Are Leukaemia-Linked Immune Cells Key Drivers of Autoimmune Disease?
New research has indicated that gene variants associated with leukaemia, can produce ‘rogue’ immune cells that drive autoimmune diseases…
Loading posts...
« Previous
1
…
54
55
56
57
58
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View